Company intelligence
Calluna Pharma
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source.
Biotechnology Research
Oslo, NO
26 employees
Founded 2024
1 public signals
About Calluna Pharma
Our innovative therapeutic approach targets upstream amplifiers of disease offering potential treatments across a diverse array of therapeutic indications. Calluna Pharma is a clinical stage biotech company driven by a commitment to improve patient outcomes in diseases where existing treatments are sub-optimal. We believe in the power of immunology to push boundaries, challenge the status quo, and develop therapies that will make a real difference for people living with serious diseases.
Verified activity
Signals from Calluna Pharma
1 published signal